SILBERMAN DAVID (Chief Financial Officer) received a stock award from ORAMED PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/1/2022ACC: 0001209191-22-043765
Officer· Chief Financial Officer
Since Jul 2021
+39K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
39K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+39K
Price / share
—
Trade value
—
% of position
56.5%
7/28/2022
69K→108K
Total
Net shares
+39K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/28/2022 | A · Award | +39K | — | — | 56.5% | 69K | 108K |
| Total | +39K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported